Kukadzi 2022: MuChina, murwere ane hupenyu hwaive pedyo nekupera akapora zvachose kubva kuleukemia nekuda CAR T-cell kurapa, iyo yaikurudzira gadziriro yomuviri inodzivirira zvirwere. Maseru ese egomarara akanyangarika nekukurumidza mukudzidza kwekutanga kwerudzi rwayo. Immune-mediated therapy, iyo yakatangwa muUnited States nemasayendisiti eACGT akadai saDr. Carl June weYunivhesiti yePennsylvania uye Dr. Michel Sadelain weChirangaridzo-Sloan Kettering Cancer Center, pakati pevamwe, iri kukurumidza kuratidza kubudirira uye kubudirira miedzo yevanhu nezviuru zvevarwere.
Mushure mekurapwa neCAR T-cell therapy, mumwe mukadzi wezera repakati akanzi akarapwa leukemia. “Maseru egomarara mumuviri wake anyangarika. Muzvinafundo Qian Cheng, director weBio-Treatment Center pachipatara cheChongqing, akati, "Ndiye murwere wekutanga kuporeswa kubva kuchirwere ichi kuburikidza nekurapa majini."
Leukemia yakaonekwa muvanhu vangangosvika mamirioni mana muChina. CAR T kurapwa ijene therapy inoshandisa masero T akagadziridzwa kurwisa cancer maseru muvarwere veleukemia. Varwere vazhinji vanorapwa nechemotherapy kana bone marrow transplants. “CAR T kurapwa imwe nzira iri nani zvikuru,” akadaro Purofesa Qian, “sezvo ichigona kuderedza kushandiswa kwemari neinenge 30% kana ichienzaniswa nokuisirwa mwongo wemapfupa uye ingangoita kuti irapwe.”
Sekureva kwaMuzvinafundo Qian, vamwe varwere vatanhatu vari kuwana gene therapy panzvimbo imwe chete vakavandudza hutano hwavo. KuChina, CAR T gene therapy ichiri muchikamu chekuyedza kiriniki, paine zvipatara gumi chete munyika yose zvakawana. Kubudirira uku kwakakurudzira timu yaQian, iyo icharamba ichitsvaga madosi kuitira kugadzira mushonga unozivikanwa.
